Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Marit van Gils and Rogier Sanders.
Connection Strength

3.075
  1. Hitting HIV's Harpoon. Immunity. 2018 07 17; 49(1):14-15.
    View in: PubMed
    Score: 0.777
  2. Opposites attract in bispecific antibody engineering. J Biol Chem. 2017 09 01; 292(35):14718-14719.
    View in: PubMed
    Score: 0.731
  3. Two-component spike nanoparticle vaccine protects macaques from SARS-CoV-2 infection. Cell. 2021 03 04; 184(5):1188-1200.e19.
    View in: PubMed
    Score: 0.232
  4. Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability. Science. 2020 08 07; 369(6504):643-650.
    View in: PubMed
    Score: 0.222
  5. Short Communication: Protective Efficacy of Broadly Neutralizing Antibody PGDM1400 Against HIV-1 Challenge in Humanized Mice. AIDS Res Hum Retroviruses. 2018 09; 34(9):790-793.
    View in: PubMed
    Score: 0.196
  6. Stabilization of the gp120 V3 loop through hydrophobic interactions reduces the immunodominant V3-directed non-neutralizing response to HIV-1 envelope trimers. J Biol Chem. 2018 02 02; 293(5):1688-1701.
    View in: PubMed
    Score: 0.186
  7. SARS-CoV-2 can recruit a heme metabolite to evade antibody immunity. Sci Adv. 2021 05; 7(22).
    View in: PubMed
    Score: 0.059
  8. SARS-CoV-2 variants of concern partially escape humoral but not T-cell responses in COVID-19 convalescent donors and vaccinees. Sci Immunol. 2021 05 25; 6(59).
    View in: PubMed
    Score: 0.059
  9. Structural and functional ramifications of antigenic drift in recent SARS-CoV-2 variants. Science. 2021 08 13; 373(6556):818-823.
    View in: PubMed
    Score: 0.059
  10. Human Milk from Previously COVID-19-Infected Mothers: The Effect of Pasteurization on Specific Antibodies and Neutralization Capacity. Nutrients. 2021 May 13; 13(5).
    View in: PubMed
    Score: 0.059
  11. High titers and low fucosylation of early human anti-SARS-CoV-2 IgG promote inflammation by alveolar macrophages. Sci Transl Med. 2021 06 02; 13(596).
    View in: PubMed
    Score: 0.059
  12. A combination of cross-neutralizing antibodies synergizes to prevent SARS-CoV-2 and SARS-CoV pseudovirus infection. Cell Host Microbe. 2021 05 12; 29(5):806-818.e6.
    View in: PubMed
    Score: 0.059
  13. The effect of spike mutations on SARS-CoV-2 neutralization. Cell Rep. 2021 03 23; 34(12):108890.
    View in: PubMed
    Score: 0.058
  14. Afucosylated IgG characterizes enveloped viral responses and correlates with COVID-19 severity. Science. 2021 02 26; 371(6532).
    View in: PubMed
    Score: 0.058
  15. Cross-Neutralization of a SARS-CoV-2 Antibody to a Functionally Conserved Site Is Mediated by Avidity. Immunity. 2020 12 15; 53(6):1272-1280.e5.
    View in: PubMed
    Score: 0.057
  16. An Alternative Binding Mode of IGHV3-53 Antibodies to the SARS-CoV-2 Receptor Binding Domain. Cell Rep. 2020 10 20; 33(3):108274.
    View in: PubMed
    Score: 0.057
  17. Comparative assessment of multiple COVID-19 serological technologies supports continued evaluation of point-of-care lateral flow assays in hospital and community healthcare settings. PLoS Pathog. 2020 09; 16(9):e1008817.
    View in: PubMed
    Score: 0.057
  18. Epitopes for neutralizing antibodies induced by HIV-1 envelope glycoprotein BG505 SOSIP trimers in rabbits and macaques. PLoS Pathog. 2018 02; 14(2):e1006913.
    View in: PubMed
    Score: 0.047
  19. Coexistence of potent HIV-1 broadly neutralizing antibodies and antibody-sensitive viruses in a viremic controller. Sci Transl Med. 2017 01 18; 9(373).
    View in: PubMed
    Score: 0.044
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.